were processed into expression values for all the 55,000 probe sets (transcripts) on each array and following the respective normalization step. Differentially expressed genes were classified according to the Gene Ontology functional category (GenMAPP v2) and functional significance of differentially expressed genes was determined using Ingenuity Pathways Analysis Software (Ingenuity Systems, http://www.ingenuity. com). Cluster and Heatmap images were generated using BRB-Array tools30. Changes in gene expression were further validated by relative quantitative RTPCR. Protein expression was monitored by Western Blot analysis, immune-histochemical and immunofluorescence methods.
INTRODUCTION AND OBJECTIVES: Gastric bypass surgery for obesity is known to be associated with post-operative hyperoxaluria, which can lead to urolithiasis and kidney damage. The objective of this study was to determine if markers of kidney injury correlated with urinary oxalate excretion. If so, such biomarkers might be early predictors of oxalate nephropathy.
METHODS: Patients were recruited from 4 large academic centers > 6 months following completion of gastric bypass surgery. Patients provided a spot urine sample for analysis of three markers of kidney injury: 8-iso-Prostaglandin F2a, N-acetyl-b-D-Glucosaminidase, and Neutrophil gelatinase-associated lipocalin. Patients also provided 24 hour urine samples for stone risk analysis.
RESULTS: 46 study patients provided samples and the average age was 48.4 + 11.3. There were 40 women and 6 men. There was no difference in the level of any of the three inflammatory markers between the study group and the reference range generated from healthy non-hyperoxaluric subjects. Neither oxalate excretion nor supersaturation of calcium oxalate correlated with any of the injury markers There was no difference noted between those with hyperoxaluria (N¼17) and those with normoxaluria (N¼29) with respect to any of the injury markers (Table 1) .
CONCLUSIONS: Though hyperoxaluria was common after bypass surgery, markers of kidney injury were not elevated after surgery. No correlation was found between urine oxalate excretion and any of the injury markers.
Source of Funding: None

MP12-08 GEOGRAPHICAL AND PREVALENCE TRENDS IN UROLITHIASIS IN ENGLAND: A TEN-YEAR REVIEW
holly ni raghallaigh*, camberley, United Kingdom; dene ellis, andrew symes, Brighton, United Kingdom INTRODUCTION AND OBJECTIVES: The prevalence of kidney stones has been increasing in the US and Europe, with stonerelated emergency attendances and procedures consequently increasing, producing a significant economic impact on hospital emergency and elective services. There is sparse available literature regarding recent incidence trends of urolithiasis in the UK. As implications for workforce planning, centralisation of stone services and the potential for identifying the highest 'risk' become increasingly relevant and we hypothesized there may be 'hot spots' of stone occurrence which could prompt further epidemiological research and help plan local stone services.
METHODS: Hospital Episode Statistics (HES) datasets and Office for National Statistics Mid-year population estimates and census data were used to calculate the occurrence of Urolithiasis England from 2003-2014. Information regarding age, gender, ethnicity, Index of Multiple Deprivation (IMD) decile and local authority district of residence were obtained. Tableau software was used to visually graph our data analysis.
RESULTS: The prevalence of urolithiasis in England grew by 33.7% over the study period. The LA with the greatest increase was South Cambridgeshire which showed a compound annual growth rate of 14.06% and absolute growth of 272.7%. In contrast, the prevalence of urolithiasis decreased in 46 of 326 local authorities, with Mid Suffolk showing a compound annual growth rate of -6.07% and an absolute decrease of 46.5%. Regional grouping of LA's was also geographically mapped. An increase in the absolute growth occurred in all age categories except 0-4 years. The age group 85+ shows the greatest growth throughout the study period, with absolute growth of 106.6% and an annual compound rate of growth of 7.35%. As seen in figure  [ 1] the 75-84 age group continued to trend upwards over the study period while the 15-44 age group stabilised from 2010 between 14.23 and 15.30 per 10,000. Prevalence in men and women has increased from 16.6 & 7.06 per 10,000 to 20.84 & 10.74 respectively. Men showed an absolute growth of 25.1%, and women an absolute growth of 52.1% CONCLUSIONS: Our work confirms the increasing prevalence of kidney stones in England, and demonstrates this prevalence is varied depending on area of residence and age. 'Hot spots' of stone activity exist, and scope for further epidemiological analysis exists.
INTRODUCTION AND OBJECTIVES:
In general, kidney stones are crystal aggregates held together by an organic matrix, which contains mainly proteins. Little is known about possible differences in the protein distribution between different stone types that likely are critical to stone pathogenesis. Enrichment of highly anionic and highly cationic proteins was observed in calcium oxalate (CaOx) stone matrix compared to urine, suggesting a role for protein aggregation in this stone process. In this study, stone matrix proteins have been quantitatively identified in 3 archival uric acid (UA) stones, and compared to the distribution observed in 8 calcium oxalate stones using a previously reported method.
METHODS: Stone matrix proteins were isolated from 3 archival UA stone samples (>95% UA content) by dissolution in sequential washes with an EDTA/SDS solution at pH¼8 with dithiothreitol added. The solubilized proteins were combined, then concentrated and desalted by ultradiafiltration. Proteomic analysis was performed at the Medical College of Wisconsin Innovation Center using non-labelled, quantitative mass spectrometry methods, including only proteins with 2 or more peptide matches at >85% confidence, after removing keratin and redundant proteins.
RESULTS: Strong protein signals (>3,000 SC per sample) were obtained from each UA matrix protein sample identifying 342 unique proteins. Of these, 180 proteins were found in both UA and CaOx stone matrix, accounting for 81% of total protein mass of the former and 94% of the latter. Albumin and uromodulin were found in both stone types, but at lower relative abundance than these proteins are found in urine, suggesting non-selective inclusion of these highly abundant urine proteins. Important differences were that none of the 5 predominant proteins in CaOx stone matrix was prominent in UA stone matrix, and highly anionic proteins were not enriched in UA stones. Highly cationic proteins were slightly more prominent in UA stone matrix than in CaOx stone former urine, but much less than observed in CaOx stone matrix. Nuclear proteins were much less strongly represented in UA stone matrix. Conversely, immunoglobulins and complement proteins were predominantly enriched in UA stone matrix and less prominent in CaOx stones.
CONCLUSIONS: Stone matrix proteins exhibit distinctly different patterns in UA compared to CaOx stones, implying different underlying pathogenesis. In particular, UA stone formation appears to be more dependent on inflammatory pathways and less dependent on cell injury processes and polyanion-polycation association compared to CaOx stone formation.
Source of Funding: Froedtert Foundation Medical College of Wisconsin
MP12-10 SNP RS17383719 IN THE PBX1 GENE IS ASSOCIATED WITH CYSTINURIA
Sabrina Reis*, Ronaldo Guimarães, Nayara Viana, Katia Leite, Giovanni Marchini, Fabio Torricelli, William Nahas, Miguel Srougi, Eduardo Mazzucchi, Sao Paulo, Brazil INTRODUCTION AND OBJECTIVES: Cystinuria is a recessive disorder characterized by impaired tubular reabsorption of cystine and dibasic amino acids. Some studies in the literature have shown mutations in the SLC3A1 gene associated with type A cystinuria that follows a complete recessive inheritance in half of the cases. The other half has been related to mutations in the SLC7A9 gene considered responsible for cystinuria type B presumably inherited by an incomplete dominant manner. Considering the paucity of studies on the genetic basis of cystinuria, we performed genome-wide human SNP array, aiming to find some single nucleotide polymorphisms (SNPs) related to cystinuria development. To confirm the microarray results we performed PCR (Polymerase Chain Reaction) searching for five SNPs that we found related to the disease and two others reported in the literature.
METHODS: DNA samples from peripheral white blood cells were extracted from eight patients with cystinuria and 10 healthy subjects with no renal calculi that composed the control group. The SNPs were genotyped using a TaqManâ SNP Genotyping Assay Kit.
RESULTS: The homozygote polymorphic genotype of SNP rs17383719 in gene PBX1 was significantly more frequent among cystinuric patients (p¼0.015). The occurrence of the polymorphic allele for this SNP was associated with a 3-fold increased risk of cystinuria (p¼0.036). The polymorphic alleles of SNPs rs913034 and rs7096453 (SVIL) were more frequent in the control group (p¼0.04 and p¼0.08, respectively). We did not detect polymorphic homozygote genotype in the SNPs for SLC7A9 (rs140134166) and SLC3A1 (rs200248046) genes.
CONCLUSIONS: This is the first study describing genetic variations in patients with cystinuria. The most important finding was the 3-fold increased risk for the development of the disease for the SNP in the PBX1 gene. PBX1 (Pre-B-cell-leukemia transcription factor 1) is a member of a transcription factors family associated with kidney development, but there are no studies in the literature associating this gene with nephrolithiasis. We postulate that the presence of SNP may change the gene expression of PBX1 affecting the renal absorption of cystine and other amino acids predisposing to nephrolithiasis. However, the prevalence of type A and type B cystine stones has not been evaluated. We aim to clarify the prevalence of type A and type B cystine stones by employing a genetic approach.
METHODS: We have accessed the 1000 Genomes Database Phase 3 (1KG) for identification of variants in the general population. To identify pathogenic mutations, we parsed the Human Gene Mutation Database (HGMD). SLC3A1 and SLC7A9 variants procured from both databases were intersected. Homozygotes, compound heterozygotes, multiple variants in cis or trans, double homozygotes, and double heterozygotes were examined. Related individuals were excluded.
